Related Experiment Video
Updated: Jul 14, 2026
11:32
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Pneumococcal vaccination in adults: recommendations, trends, and prospects
Paul V Targonski1, Gregory A Poland
1Department of Internal Medicine, Mayo Vaccine Research Group, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Cleveland Clinic Journal of Medicine
|June 16, 2007
Summary
Pneumococcal vaccination is recommended for older adults and high-risk individuals. While its overall effectiveness is debated, it significantly reduces the risk of invasive pneumococcal disease.
Area of Science:
- Infectious Diseases
- Vaccinology
- Public Health
Background:
- Streptococcus pneumoniae poses a significant health risk, particularly to older adults and immunocompromised individuals.
- The US Centers for Disease Control and Prevention (CDC) recommends pneumococcal vaccination for individuals aged 65 and older, and for younger individuals with specific high-risk conditions.
- Despite recommendations, the precise efficacy of pneumococcal vaccines remains a subject of ongoing scientific discussion and research.
Purpose of the Study:
- To evaluate the overall effectiveness of pneumococcal vaccination.
- To clarify the benefits of pneumococcal vaccination in preventing pneumonia, death, and invasive pneumococcal disease.
- To provide evidence-based insights into the value of pneumococcal vaccination for public health recommendations.
Main Methods:
- Review of existing scientific literature, including observational studies and clinical trials.
- Analysis of data comparing vaccinated and unvaccinated populations.
- Assessment of vaccine impact on various outcomes such as pneumonia, all-cause mortality, and invasive pneumococcal disease.
Main Results:
- Most observational studies suggest a beneficial effect of pneumococcal vaccination.
- Clinical trials, when analyzed as a group, yielded inconclusive results regarding overall efficacy.
- Pneumococcal vaccination was found to significantly decrease the risk of invasive pneumococcal disease.
Conclusions:
- Pneumococcal vaccination is a valuable public health intervention due to its proven ability to reduce the incidence of invasive pneumococcal disease.
- While the vaccine's impact on preventing pneumonia or all-cause mortality may be debated, its role in preventing severe invasive infections is well-established.
- The recommendation for pneumococcal vaccination in specific populations remains justified based on its efficacy against invasive disease.
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...